A
Arkeon
Turns CO2 into functional, carbon-negative ingredients for food
About Arkeon
Arkeon Bio is a startup operating in the biotechnology sector. The company's primary focus is on leveraging advanced technologies to develop innovative solutions in the field of biology. Although the specific details of their products or services are not explicitly mentioned, it can be inferred that they are likely involved in research and development, potentially creating new biological products or improving existing ones.
Read full description
The company's target market is likely to be other businesses within the biotech sector, including pharmaceutical companies, research institutions, and healthcare providers. They may also serve clients in related industries that require biological solutions, such as agriculture, food production, and environmental conservation.
Arkeon Bio's business model is not explicitly stated, but based on industry norms, it likely involves generating revenue through the sale of their biological products or licensing their technologies to other companies. They may also earn income from partnerships, grants, or contracts for specific research projects.
In summary, Arkeon Bio is a biotech startup that uses advanced technologies to develop innovative biological solutions. Their clients are likely to be other businesses in the biotech sector or related industries, and they generate revenue through the sale of products, licensing of technologies, and research contracts.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Tulln, Austria
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 59.1/100
- Sub-industry
- Waste Solution, Innovative Food
- Sector
- Energy, Biotechnology, Synthetic Biology, Spinout, Alternative Protein, Meat Substitute, Sustainable Development Goals, Carbon Capture and Storage, Seafood Substitute
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Dec 2022 | $4.4M | $36M | ICL · FoodHack · Tet Ventures · aws Gründungsfonds | ↗ |
| SEED✓Equity / VC | Mar 2022 | $7.2M | $29M | ReGen Ventures · Synthesis Capital | ↗ |
Growth signals
Latest recorded traffic for Arkeon is 900 monthly website visits, down 43.8% over the last three months. Arkeon's team declined 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
ReGen Ventures
Synthesis Capital
ICL
FoodHack
Tet Ventures
aws Gründungsfonds
Other known investors7 additional known investors
University of Vienna
Franziskus Schnabel
Look Up Ventures
Partners in Clime
Plug and Play
Simon Fabich
Triple Impact Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arkeon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arkeon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.